Published in Gut on December 05, 2017
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy (2020) 3.93
Split dosing with a low-volume preparation is not inferior to split dosing with a high-volume preparation for bowel cleansing in patients with a history of colorectal resection: a randomized trial. Endoscopy (2015) 2.64
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol (2013) 2.37
Management of recurrent symptoms after per-oral endoscopic myotomy in achalasia. Gastrointest Endosc (2017) 1.96
Development of a prediction model of adverse events after stent placement for esophageal cancer. Gastrointest Endosc (2015) 1.59
Clinical outcomes following stent placement in refractory benign esophageal stricture: a systematic review and meta-analysis. Endoscopy (2015) 1.48
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol (2016) 1.40
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
EUS-guided gold fiducial placement and migration rate. Gastrointest Endosc (2014) 1.11
The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy (2015) 1.08
Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy (2016) 0.99
Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut (2015) 0.96
The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc (2013) 0.91
Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection. Gut (2014) 0.90
Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy (2017) 0.86
The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. United European Gastroenterol J (2015) 0.81
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma. Cancer Med (2015) 0.81
Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78
Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77
Endoscopic mucosal resection of large colorectal adenomas: Only for expert centers? United European Gastroenterol J (2015) 0.77
Early adverse events of per-oral endoscopic myotomy. Gastrointest Endosc (2016) 0.77
Probiotics in the Treatment of Diverticular Disease. A Systematic Review. J Gastrointestin Liver Dis (2016) 0.76
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk. Cancer Med (2016) 0.76
A novel prepless X-ray imaging capsule for colon cancer screening. Gut (2015) 0.76
Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest Endosc (2017) 0.76
A 28-year-old woman with hypertrophic right leg and haematochezia. Gut (2015) 0.75
A 52-year-old man with heartburn and weight loss. Gut (2015) 0.75
Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus. Gut (2020) 0.75
Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients. Gut (2017) 0.75
Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection. JAMA Intern Med (2014) 0.75
Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer. Gastrointest Endosc (2015) 0.75
Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol (2016) 0.75